This research study is enrolling participants diagnosed with breast cancer and receiving/received chemotherapy and/or endocrine therapy. The study's primary objective is to assess the differences in the use of herbs and supplements among the populations served at Cleveland Clinic Florida and Ohio by administering a participant-reported questionnaire.
Age: 18 years and older.
Breast cancer diagnosis at pathologic stage (I, II, and III)
Participants with regional lymph node involvement
Received Chemotherapy and/ or Endocrine therapy
Under 18 years of age
Prior history of cancer diagnosis
Unable or unwilling to participate in the survey
Distant Metastatic Disease
Established stages I, II, and III breast cancer patients at Cleveland Clinic Florida and Ohio who received care will be screened by the research fellow before or after their oncology visit.
Case-only
Cross-sectional
No intervention
Other interventionParticipants will complete a one-time 33-question survey. The survey is comprised of three sections: (1) Section A includes 12 questions related to demographic information, (2) Section B consists of 2 questions addressing treatment characteristics, \& (3) Section C contains 19 questions focusing on supplement usage.
Influence of ethnicity on herb/supplement usage among early stage breast cancer participants.
Univariate analysis in which Chi-square test or Fisher's exact test will be performed.
Determine the ten most common herbs and supplements by frequency of use in each Cancer Center.
Determine the Prevalence of Herbs and Supplements in breast cancer patients.
Assess potential associations between Conventional treatments and Herbs/Supplements.
Measured by multiple logistic regression model
Association between cancer stage and herbs/supplement usage.
Measured by multiple logistic regression model
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: